Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug‐Drug Interaction Study in Healthy Females

Lemborexant is a dual orexin receptor antagonist approved in multiple countries including the United States, Canada, and Japan for the treatment of insomnia in adults. As women of childbearing potential may be prescribed insomnia drugs, a drug‐drug interaction study was conducted. This single‐center...

Descripción completa

Detalles Bibliográficos
Autores principales: Landry, Ishani, Aluri, Jagadeesh, Hall, Nancy, Filippov, Gleb, Dayal, Satish, Moline, Margaret, Reyderman, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453935/
https://www.ncbi.nlm.nih.gov/pubmed/34107159
http://dx.doi.org/10.1002/cpdd.953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453935/
https://www.ncbi.nlm.nih.gov/pubmed/34107159
http://dx.doi.org/10.1002/cpdd.953

Ejemplares similares